US 9309535
Combination anti-HIV vectors, targeting vectors, and methods of use
granted A61KA61K31/7105A61K38/53
Quick answer
US patent 9309535 (Combination anti-HIV vectors, targeting vectors, and methods of use) held by The Regents of the University of California expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/7105, A61K38/53, A61K48/0066, A61P